Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-331P is a pseudogene corresponding to a member of the U6 small nuclear RNA gene family. U6 snRNA is an essential component of the spliceosome in its functional form, involved in pre-mRNA splicing[2]. However, RNU6-331P itself is a pseudogene, meaning it is a genomic sequence related to the functional U6 snRNA genes but is largely nonfunctional due to accumulated mutations and lack of required transcriptional elements. Pseudogenes are prevalent in the human genome, often reflecting duplication events of essential RNA genes such as U6, but do not participate actively in cellular processes[1][3]. There are no reported roles for RNU6-331P in disease, nor does it serve as a biomarker, drug target, or possess any mechanism of action relevant to therapy or patient monitoring. If you need structured information specifically on the functional U6 small nuclear RNA, refer to entries such as "RNA, U6 small nuclear 1" (RNU6-1), which have documented biological roles in splicing and potential research associations with cancer and other diseases[2][5][6][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 331, pseudogene (RNU6-331P).